---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-007882"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2021-11-12T23:59:59+00:00"
generated_at: "2026-06-28T09:36:53.085306+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Psychemedics Q3 revenue up 29% to $6.7M; net income $0.13 EPS vs loss of $0.20

## Summary
- Revenue $6.7M vs $5.2M YoY (+29%); domestic revenue up 27% YoY.
- Net income of $0.7M ($0.13 diluted EPS) vs net loss of $1.1M (-$0.20).
- Employee Retention Credit of $0.8M reduced costs; dividend remains suspended.
- Exploration of strategic alternatives continues with JMP Securities; no timetable.
- PPP loan of $2.2M fully forgiven by SBA in July 2021.

## SEC filing metadata
- accession: 0001171843-21-007882
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2021-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184321007882/0001171843-21-007882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184321007882/f8k_111221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-007882
- JSON: https://secwatch.observer/filing/0001171843-21-007882.json
- Plain text: https://secwatch.observer/filing/0001171843-21-007882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.